Login

CERN-hosted Workshop on Design Characteristics of a Novel Linear Accelerator for Challenging Environments - Improving global access to radiation therapy

7โ€“8 Nov 2016
CERN
Europe/Zurich timezone

Contribution List

50 out of 50 displayed
Export to PDF
  1. 2. I. Welcome to CERN: Frederick Bordry
    Frederick Bordry (CERN)
    07/11/2016, 08:30
  2. 3. II. Welcome and Goals of the Workshop: Norman Coleman, Manjit Dosanjh and David Pistenmaa
    C. Norman Coleman (National Cancer Institute), David Pistenmaa, Manjit Dosanjh
    07/11/2016, 08:35
  3. 4. III. A. Summary of findings of the Global Task Force for Radiation Control Cancer (GTFRCC)
    Mary Gospodarowicz
    07/11/2016, 08:50
  4. 18. III. B. Balancing Equity and Advancement in Radiotherapy: How Economics Can Help Solve Global Health Challenges
    Danielle Rodin
    07/11/2016, 09:05
  5. 41. III. C. Cobalt-60 and Cancer Treatment: the NNSA Radiological Security Mission
    Katherine Holt
    07/11/2016, 09:20
  6. 19. III. D. Treatment not Terror: Improving Cancer Treatment while Reducing Security Risks
    Miles Pomper
    07/11/2016, 09:35
  7. 20. IV. A. IAEA's perspective
    Zubi Zubizarreta
    07/11/2016, 10:25
  8. 8. IV. B. Open Discussion
    07/11/2016, 10:45
  9. 22. V. A. Radiation Oncology in Africa; Current State and Future Goals
    Surbhi Grover
    07/11/2016, 11:00
  10. 23. V. B. Machine Parameters and Machine Operational Features to Satisfy Requirements
    Ahmed Meghzifene
    07/11/2016, 11:15
  11. 24. V. C. โ€œDreamlinerโ€ Novel Linear Accelerator Features for Challenging Environments
    David Pistenmaa (ICEC)
    07/11/2016, 11:35
  12. 25. VI. NASAโ€™s Experience in the Modular Design of Complex Systems
    Ron Cobbs
    07/11/2016, 11:40
  13. 46. VII. A. 1. Goals of Session VII
    Alberto Degiovanni (CERN), Ugo Amaldi (TERA Foundation (IT))
    07/11/2016, 13:00
  14. 47. VII. A. 2. Experience gained from the GlobalDiagnostiX project
    Romain Sahli
    07/11/2016, 13:05
  15. 51. VII. A. 3. Problems posed by "difficult" environments to present linac-based systems
    John Allen
    07/11/2016, 13:22
  16. 50. VII. A. 4. Electron Linac Projects in Pakistan with CERN support
    Sumaira Zeeshan
    07/11/2016, 13:39
  17. 48. VII. A. 5. IORT linac and possible developments
    Luigi Picardi
    07/11/2016, 13:56
  18. 49. VII. A. 6. Experience on Electron Linacs at NCBJ (Poland)
    Przemek Adrich
    07/11/2016, 14:13
  19. 52. VII. A. 7. Robust X-ray imaging
    David Jaffray
    07/11/2016, 14:30
  20. 53. VII. A. 8. Lower cost RT through new software tools (optimization and automation)
    Johan Lof
    07/11/2016, 14:47
  21. 54. VII. A. 9. Shielding in "difficult" environments
    Pawel Krawczyk
    07/11/2016, 15:30
  22. 56. VII. A. 10. PHASER: Application of Advanced RF Linac Technology to Medical Accelerators
    Billy Loo, Sami Tantawi
    07/11/2016, 15:47
  23. 55. VII. A. 11. General Design Considerations on Structures, Power Sources and Accessories
    Maurizio Vretenar
    07/11/2016, 16:04
  24. 57. VII. A. 12. Conclusions
    Ugo Amaldi (TERA Foundation (IT))
    07/11/2016, 16:21
  25. 43. VII. B. Open discussion. Co-moderators: Ugo Amaldi, Alberto Degiovanni and David Pistenmaa
    07/11/2016, 16:30
  26. 44. VIII. A. Recommendations emanating from Session VII
    Alberto Degiovanni (CERN), Ugo Amaldi (TERA Foundation (IT))
    08/11/2016, 08:35
  27. 45. VIII. B. Open discussion
    08/11/2016, 09:00
  28. 30. IX. A. How do we translate design characteristics into a working machine (From machine shop to the clinic)?
    Jacques Bernier (GSMN)
    08/11/2016, 10:25
  29. 31. IX. B. Challenges in introducing new technology in the developing world
    Andras Fehervary
    08/11/2016, 10:40
  30. 34. IX. C. Entrepreneurial strategies to make it happen
    Ajit Singh
    08/11/2016, 10:55
  31. 32. IX. D. Determining the cost of new technologies such as the linear accelerator under consideration
    Yolande Lievens
    08/11/2016, 11:10
  32. 35. X. A. 1. Clinical considerations
    C. Norman Coleman (National Cancer Institute)
    08/11/2016, 11:30

    Norman Coleman for Niloy Datta

    Go to contribution page
  33. 58. X. A. 2. Equipment and facility needs.
    Ahmed Meghzifene
    08/11/2016, 11:45
  34. 36. X. B. 1. Using modern technology to share medical knowledge worldwide
    Zubi Zubizarreta
    08/11/2016, 13:00
  35. 59. X. C. 1. Overview by the moderator
    Yolande Lievens
    08/11/2016, 13:25
  36. 60. X. C. 2. Presentations by panel members: Norman Coleman, ICEC; Bruce Curran, AAPM; Nelly Enwerem-Bromson, IAEA; Patricia Hardenbergh, ASTRO; Ahmed Meghzifene, IAEA; Yakov Pipman, MPWB
    Ahmed Meghzifene, Bruce Curran, C. Norman Coleman (National Cancer Institute), Nelly Enwerem-Bromson, Patti Hardenbergh, Dr Yakov Pipman (MPWB)
    08/11/2016, 13:30
  37. 61. X. C. 3. Open discussion
    08/11/2016, 14:00
  38. 17. XII. Concluding Remarks by Workshop Co-organizers
    C. Norman Coleman (National Cancer Institute), David Pistenmaa (ICEC), Manjit Dosanjh (CERN)
    08/11/2016, 15:00
  39. 62. XI. A. 1. Design characteristics for a novel linear accelerator for challenging environments
    Alberto Degiovanni (CERN)
    08/11/2016, 15:05
  40. 63. XI. A. 2. Achieving and sustaining the necessary infrastructure in challenging environments: Can we get by with less?
    Bhadrasain Vikram
    08/11/2016, 15:20
  41. 64. XI. A. 3. Estimating the needs and planning for sustainable training of radiotherapy professional and ancillary staff in developing countries
    Onyinye Balogun
    08/11/2016, 15:35
  42. 39. XI. B. Next steps
    C. Norman Coleman (National Cancer Institute), David Pistenmaa (ICEC), Manjit Dosanjh (CERN)
    08/11/2016, 16:20
    1. Preparation of a Summary Report of the Workshop
    2. Dissemination of information from the Workshop
    3. Recommended additional actions
    Go to contribution page
  43. 21. IV. C. Industry's experience
    Andras Fehervary
  44. 33. IX. E. How do you deal with cost-effectiveness of a new linear accelerator and its implications for low-resource settings?
    Danielle Rodin
  45. 42. VII. (Part 2) A. Technical presentations. Co-moderators: Ugo Amaldi and Alberto Degiovanni
    Alberto Degiovanni (CERN), Ugo Amaldi (TERA Foundation (IT))

    10 Design Considerations (Accelerator Structure operating Frequency; Types of Structure; Power Sources (? Magnetrons); Multi-leaf collimator): Maurizio Vretenar
    11 PHASER: Application of Advanced RF Linac Technology to Medical Accelerators: Sami Tantawi and Billy Loo
    12 Conclusions: Ugo Amaldi

    Go to contribution page
  46. 27. VII. B. Considerations at TERA
  47. 28. VII. C. Considerations from other organizations
  48. 29. VII. D. Open Discussion
  49. 37. X. C. Panel Discussion: Planning for Sustainable Training of Professional and Ancillary Personnel in Developing Countries. Moderator: Yolande Lievens
    Yolande Lievens
    1. Overview by the moderator
    2. Presentations by panel members: Norman Coleman, ICEC; Bruce Curran, AAPM; Nelly Enwerem-Bromson, IAEA; Patricia Hardenbergh, ASTRO; Ahmed Meghzifene, IAEA; Yakov Pipman, MPWB
    3. Open discussion
    Go to contribution page
  50. 38. XI. A. Summary of recommendations from the Workshop
    C. Norman Coleman (National Cancer Institute), David Pistenmaa (ICEC), Manjit Dosanjh (CERN)

    3:00 - 1. Design characteristics for a novel linear accelerator for challenging environments: Alberto Degiovanni or designee
    3:15 - 2. Achieving and sustaining the necessary infrastructure in challenging environments: Can we get by with less? Vik Vikram
    3:30 - 3. Estimating the needs and planning for sustainable training of radiotherapy professional and ancillary staff in developing...

    Go to contribution page